Rhonda Janice Pacheco
CIK: 0002111489
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Pacheco Rhonda Janice
Pacheco Rhonda Janice (SEC CIK 0002111489) files insider reports with the SEC as President, U.S. Business Unit of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 3 ownership filings by Pacheco Rhonda Janice (1 Form 3, 2 Form 4), filed between Mar 18, 2026 and Aug 12, 2026. Those filings report 2 transactions, from Jul 1, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pacheco Rhonda Janice's filings is in CAMBRIDGE, MA.
Recent filings by Pacheco Rhonda Janice
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pignagnoli Agosti Marcello, Head, Strat. & Port. Dev